News & Perspective

Nov 27, 2001

Nov 27, 2001

CDC smallpox plan favors focused vaccination program over mass campaign

(CIDRAP News) – If smallpox reappears in the United States, health authorities will strive to trace and vaccinate everyone who has had contact with infected or exposed persons but probably will not mount any mass vaccination campaigns, according to a draft plan released Monday by the Centers for Disease Control and Prevention (CDC).

Dec 19, 2001

Dec 19, 2001

Anthrax vaccine to be offered to postal and Capitol workers

(CIDRAP News) – Because of a small theoretical risk that anthrax spores can hide in the lungs for up to 100 days and grow after antibiotic treatment is stopped, the anthrax vaccine and an extension of antibiotic treatment will be offered to people who may have been exposed in the recent anthrax attacks, federal health officials announced yesterday afternoon.

Feb 01, 2002

Feb 01, 2002

FDA clears BioPort to distribute anthrax vaccine

(CIDRAP News) – BioPort Corp of Lansing, Mich., yesterday received Food and Drug Administration (FDA) approval to begin routine distribution of its anthrax vaccine after more than 3 years of effort to bring its operation up to federal standards.

"FDA is now satisfied that BioPort's renovated facility can produce a vaccine that meets FDA standards for safety and efficacy," the agency said in a news release.

Jul 01, 2002

Jul 01, 2002

Pentagon will turn over part of anthrax vaccine supply for civilian use

July 1, 2002 (CIDRAP News) – About half of the nation's supply of anthrax vaccine—previously dedicated almost entirely to military use—will henceforward be set aside for civilian use in the event of another anthrax attack, federal defense and health officials announced Jun 28.

Nov 05, 2002

Nov 05, 2002

FDA licenses repackaged smallpox vaccine from federal stockpile

(CIDRAP News) – The Food and Drug Administration (FDA) has updated the licensing for the government's decades-old stockpile of Dryvax smallpox vaccine by approving a new vaccine kit that includes a new diluent and bifurcated needles, according to federal officials.

Nov 22, 2002

Nov 22, 2002

Homeland Security law leaves HHS in control of bioterrorism preparedness

(CIDRAP News) – In passing a bill to create a Department of Homeland Security (DHS) this week, Congress left the Department of Health and Human Services (HHS) in charge of most bioterrorism preparedness and civilian biodefense research programs—to the relief of medical research and public health groups.

Dec 16, 2002

Dec 16, 2002

Half of second target group for smallpox shots may refuse them, officials estimate

(CIDRAP News) – Federal health officials project that about half of the estimated 10 million health and emergency response workers targeted for the second round of smallpox vaccinations will refuse the shots.

Feb 06, 2003

Feb 06, 2003

No adverse reactions in first 687 smallpox shots, CDC says

(CIDRAP News) – With about 700 people vaccinated so far in the government's campaign to immunize frontline healthcare workers against smallpox, no adverse events have been reported, the head of the Centers for Disease Control and Prevention (CDC) said today.

Jun 20, 2003

Jun 20, 2003

ACIP: Don't broaden smallpox vaccination program now

(CIDRAP News) – Because of the risk of heart inflammation, the Advisory Committee on Immunization Practices (ACIP) recommended yesterday that the federal smallpox immunization program not expand now beyond smallpox response teams to the larger population of health workers and emergency responders.

Nov 19, 2003

Nov 19, 2003

Vaccines might have contributed to death of Army reservist

(CIDRAP News) – A combination of vaccines that included smallpox and anthrax might have contributed to the death of a young Army reservist last April, the Department of Defense (DoD) announced today.

Pages

by Topic

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»